<DOC>
	<DOCNO>NCT00366704</DOCNO>
	<brief_summary>The purpose study determine effect bifeprunox risperidone body weight patient schizophrenia .</brief_summary>
	<brief_title>Study Comparing Bifeprunox Risperidone Treatment Outpatients With Schizophrenia With Weight Primary Endpoint</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Inclusion criterion : Current treatment least 3 month risperidone . Primary diagnosis schizophrenia . Total Positive Negative Symptoms Scale ( PANSS ) score &lt; = 70 screen baseline . Exclusion criterion : Psychiatric diagnosis schizophrenia assess modify Mini International Neuropsychiatric Interview ( MINI ) consider investigator primary psychiatric diagnosis . History presence clinically significant cardiovascular , endocrine , hepatic , renal medical disease might detrimental subject confound study . History suicide attempt within 3 year day 1 significant immediate risk violence suicidality .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Schizophrenia</keyword>
</DOC>